Department of Clinical Sciences, Anaesthesia and Intensive Care, Lund University, Skåne University Hospital, Malmö, Sweden.
Anaesthesia and Intensive Care, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Resuscitation. 2023 Oct;191:109949. doi: 10.1016/j.resuscitation.2023.109949. Epub 2023 Aug 25.
Several different scoring systems for early risk stratification after out-of-hospital cardiac arrest have been developed, but few have been validated in large datasets. The aim of the present study was to compare the well-validated Out-of-hospital Cardiac Arrest (OHCA) and Cardiac Arrest Hospital Prognosis (CAHP)-scores to the less complex MIRACLE2- and Target Temperature Management (TTM)-scores.
This was a post-hoc analysis of the Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial. Missing data were handled by multiple imputation. The primary outcome was discriminatory performance assessed as the area under the receiver operating characteristics-curve (AUROC), with the outcome of interest being poor functional outcome or death (modified Rankin Scale 4-6) at 6 months after OHCA.
Data on functional outcome at 6 months were available for 1829 cases, which constituted the study population. The pooled AUROC for the MIRACLE2-score was 0.810 (95% CI 0.790-0.828), 0.835 (95% CI 0.816-0.852) for the TTM-score, 0.820 (95% CI 0.800-0.839) for the CAHP-score and 0.770 (95% CI 0.748-0.791) for the OHCA-score. At the cut-offs needed to achieve specificities >95%, sensitivities were <40% for all four scoring systems.
The TTM-, MIRACLE2- and CAHP-scores are all capable of providing objective risk estimates accurate enough to be used as part of a holistic patient assessment after OHCA of a suspected cardiac origin. Due to its simplicity, the MIRACLE2-score could be a practical solution for both clinical application and risk stratification within trials.
已经开发出了几种不同的评分系统,用于对院外心脏骤停后进行早期风险分层,但很少有评分系统在大型数据集上得到验证。本研究的目的是比较经过充分验证的院外心脏骤停(OHCA)和心脏骤停医院预后(CAHP)评分与不太复杂的 MIRACLE2 和目标温度管理(TTM)评分。
这是对目标低温与院外心脏骤停后目标常温治疗(TTM2)试验的事后分析。通过多次插补处理缺失数据。主要结局是通过接受者操作特征曲线下面积(AUROC)评估的判别性能,感兴趣的结局是 OHCA 后 6 个月时功能预后不良或死亡(改良 Rankin 量表 4-6 级)。
共有 1829 例患者的 6 个月时功能结局数据可用,构成了研究人群。MIRACLE2 评分的汇总 AUROC 为 0.810(95%CI 0.790-0.828),TTM 评分的 AUROC 为 0.835(95%CI 0.816-0.852),CAHP 评分的 AUROC 为 0.820(95%CI 0.800-0.839),OHCA 评分的 AUROC 为 0.770(95%CI 0.748-0.791)。在达到特定特异性>95%所需的截止值时,所有四个评分系统的敏感性均<40%。
TTM、MIRACLE2 和 CAHP 评分均能够提供足够准确的客观风险估计,可用于疑似心源性 OHCA 后整体患者评估的一部分。由于其简单性,MIRACLE2 评分可以作为临床试验中临床应用和风险分层的实用解决方案。